Relative to controls, ACD model mice exhibited enhancements in TNF-α, IL-6, and IL-17 levels (P < 0.01), while TGF-β and IL-10 levels were significantly reduced in these ACD model mice (P < 0.05 or P < 0.01). The gene discussed is TGFB1; the disease is granular corneal dystrophy type II.